Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

HRT for preserving bone density in postmenopausal women

Nov. 20, 1996

Immunoregulating effect of IL-4 in IDDM

Nov. 20, 1996

Pharming granted orphan drug status for Pompe's disease therapy

Nov. 20, 1996

Warner-Lambert claims lipid-regulating agents for vascular disease, diabetes

Nov. 20, 1996

FDA approves treatment for homocystinuria

Nov. 19, 1996

Growth stimulant reported by American Cyanamid

Nov. 19, 1996

Second NDA submitted for Crinone

Nov. 15, 1996

Lilly reports agents to treat menopause-related conditions

Nov. 15, 1996

Vasomax enters pivotal trials

Nov. 15, 1996

PKC inhibitors from Lilly for various therapeutic indications

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...